AI-generated summary
The authors review the use of the excimer laser in dermatology since first reports in 1997. They describe it as an improvement on conventional phototherapy because it involves a lower cumulative UV dose and targets individual lesions. They report that case studies have covered conditions such as vitiligo, psoriasis, acne and alopecia areata, and they list future priorities including large-scale evaluation.
- Limits stated in the abstract
- The abstract describes an overview of publications to date and gives no sample sizes, outcomes or quantitative results.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Phototherapy, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.